Western Standard LLC’s Q32 Bio QTTB Stock Holding History

Western Standard LLC’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13,892	Closed	-$293K	–	38
2023 Q3	$293K	Buy	+13,892	New	+$283K	0.26%	27

Other funds holding QTTB

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GKFF

George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return

Western Standard LLC's QTTB Position: Q4 2023 in Review

Western Standard LLC sold out of Q32 Bio (QTTB) in Q4 2023, closing a stake of 13,892 shares — an estimated $293K sold.

Western Standard LLC first reported a position in QTTB in Q3 2023 and held it in 1 quarter. The position peaked at $293K in Q3 2023. 57 funds tracked by Wall St. Rank hold QTTB as of Q4 2023.

Western Standard LLC reported no remaining Q32 Bio position as of Q4 2023 after selling out during the quarter.
Western Standard LLC sold 13,892 Q32 Bio shares in Q4 2023, an estimated $293K.
Western Standard LLC first reported a position in Q32 Bio in Q3 2023 and held it in 1 quarter.
Western Standard LLC's Q32 Bio position peaked at $293K in Q3 2023.
57 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2023.

Based on Western Standard LLC's 13F filing for Q4 2023, filed 14 Feb 2024.